Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heme Arginate Effects on MRI During Ischemia
NCT01461512Phase 2Unknown
- Start
- Jan 2009
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heme arginate in ischemia-reperfusion injury (IRI). Status: unknown.
02
Drugs
heme arginate
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01461512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461512.